Skip to main content
Top

Angiogenesis

Issue 1/2004

Content (10 Articles)

Quantitative Angiogenesis Assays in vivo – A Review

Jurjees Hasan, S.D. Shnyder, M. Bibby, J.A. Double, R. Bicknel, G.C. Jayson

Early Inducible Nitric Oxide Synthase 2 (NOS 2) Activity Enhances Ischaemic Skin Flap Survival

Sunao Furuta, Peter Vadiveloo, Rosalind Romeo-Meeuw, Wayne Morrison, Alastair Stewart, Geraldine Mitchell

Different Mechanisms Lead to the Angiogenic Process Induced by Three Adenocarcinoma Cell Lines

Lilia E. Davel, Laura Rimmaudo, Alejandro Español, Eulalia de la Torre, María Adela Jasnis, María Laura Ribeiro, Tomomi Gotoh, Eugenia Sacerdote de Lustig, María Elena Sales

Angiogenesis Inhibition by Angiostatin, Endostatin and TNP-470 Prevents Cyclophosphamide Induced Cystitis

Wolf-Dietrich Beecken, Tobias Engl, Roman Blaheta, Wassilios Bentas, Eike-Gerd Achilles, Dietger Jonas, Yuen Shing, Kevin Camphausen

Inhibition of Angiogenesis by Aβ Peptides

Daniel Paris, Kirk Townsend, Amita Quadros, James Humphrey, Jiazhi Sun, Steven Brem, Marguerite Wotoczek-Obadia, Anthony DelleDonne, Nikunj Patel, Demian F. Obregon, Robert Crescentini, Laila Abdullah, Domenico Coppola, Amyn M. Rojiani, Fiona Crawford, Saïd M. Sebti, Michael Mullan

Instructions for Authors

Instructions for Authors

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine